Alterations of H19 imprinting and IGF2 replication timing are infrequent in Beckwith-Wiedemann syndrome

Genomics

Volumn 65, Issue 3, 2000, Pages 234-242

  Squire, Jeremy A ^a,b   Li, Madeline ^a,c   Perlikowski, Sandra ^a,b   Fei, Yan Ling ^a,c   Bayani, Jane ^a,b   Zhang, Zong Mei ^a,b   Weksberg, Rosanna ^a,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BECKWITH WIEDEMANN SYNDROME; CHROMOSOME 11P; CHROMOSOME INVERSION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 11; CLINICAL ARTICLE; DNA METHYLATION; EXTRACHROMOSOMAL INHERITANCE; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE REPLICATION; GENOME IMPRINTING; HUMAN; HUMAN CELL; KARYOTYPE; PRIORITY JOURNAL;

EID: 0034192688     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2000.6155     Document Type: Article

References (66)

1. Barlow D. R. Competition - A common motif for the imprinting mechanism? EMBO J. 16:1997;6899-6905.
2. Brown K. W., Villar A. J., Bickmore W., Clayton-Smith J., Catchpoole D., Maher E. R., Reik W. Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway. Hum. Mol. Genet. 5:1996;2027-2032.
3. Catchpoole D., Lam W. W. K., Valler D., Temple I. K., Joyce J. A., Reik W., Schofield P. N., Maher E. R. Epigenetic modification and uniparental inheritance of H19 in Beckwith-Wiedemann syndrome. J. Med. Genet. 34:1997;353-359.
4. Dao D., Frank D., Qian N., O'Keefe D., Vosatka R. J., Walsh C. P., Tycko B. IMPT1, an imprinted gene similar to polyspecific transporter and multi-drug resistance genes. Hum. Mol. Genet. 7:1998;597-608.
5. Douc-Rasy S., Barrois M., Fogel S., Ahomadegbe J. C., Stehelin D., Coll J., Riou G. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Oncogene. 12:1996;423-430.
6. Dracopoli N. C. Current Protocols in Human Genetics. 1995;Wiley, New York.
7. Eggenschwiler J., Ludwig T., Fisher P., Leighton P. A., Tilghman S. M., Efstratiadis A. Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev. 11:1997;3128-3142.
8. Frohman M. A., Dush M. K., Martin G. R. Rapid production of full-length cDNAs from rare transcripts: Amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA. 85:1987.
9. Greally J. M., Guinness M. E., McGrath J., Zemel S. Matrix-attachment regions in the mouse chromosome 7F imprinted domain. Mamm. Genome. 8:1997;805-810.
10. Greally J. M., Starr D. J., Hwang S., Song L., Jaarola M., Zemel S. The mouse H19 locus mediates a transition between imprinted and non-imprinted DNA replication patterns. Hum. Mol. Genet. 7:1998;91-95.
11. KIP2 mutations in Beckwith-Wiedemann syndrome. Hum. Genet. 100:1997;681-683.
12. Hatada I., Ohashi H., Fukushima Y., Kaneko Y., Inoue M., Komoto Y., Okada A., Ohishi S., Nabetani A., Morisaki H., Nakayama M., Niikawa N., Mukai T. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat. Genet. 14:1996;171-173.
13. Henry I. Uniparental paternal disomy in a genetic cancer-predisposion syndrome. Nature. 351:1991;665-667.
14. Henry I. Somatic mosaicism for partial paternal isodisomy in Wiedeman-Beckwith syndrome: A post-fertilization event. Eur. J. Hum. Genet. 1:1993;19-29.
15. Jones P. A., Laird P. W. Cancer epigenetics comes of age. Nat. Genet. 21:1999;163-167.
16. Jouvenot Y., Poirier F., Jami J., Paldi A. Biallelic trancription of Igf2 and H19 in individual cells siggests a post-transcriptional contribution to genomic imprinting. Curr. Biol. 9:1999;1199-1202.
17. Joyce J. A., Lam W. K., Catchpoole D. J., Jenks P., Reik W., Maher E. R., Schofield P. N. Imprinting of IGF2 and H19: Lack of reciprocity in sporadic Beckwith-Wiedemann syndrome. Hum. Mol. Genet. 6:1997;1543-1548.
18. Joyce J. A., Schofield P. N. Genomic imprinting and cancer. Mol. Pathol. 51:1998;185-190.
19. Kawame H., Gartler S. M., Hansen R. S. Allele-specific replication timing in imprinted domains: Absence of asynchrony at several loci. Hum. Mol. Genet. 4:1995;2287-2293.
20. Kitsberg D., Selig S., Brandeis M., Simon I., Keshet I., Driscoll D. J., Nicholls R. D., Cedar H. Allele-specific replication timing of imprinted gene regions. Nature. 364:1993;459-463.
21. Koufos A., Grundy P., Morgan K., Aleck K. A., Hadro T., Lampkin B. C., Kalbakji A., Cavenee W. K. Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am. J. Hum. Genet. 44:1989;711-719.
22. KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation. J. Med. Genet. 36:1999;518-523.
23. KIP2 mutation in Beckwith-Wiedemann syndrome. Am. J. Hum. Genet. 61:1997a;304-309.
24. Lee M. P., DeBaun M. R., Mitsuya K., Galonek H. L., Brandenburg S., Oshimura M., Feinberg A. P. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KvLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insuliln-like growth factor II imprinting. Proc. Natl. Acad. Sci. USA. 96:1999;5203-5208.
25. Lee M. P., Hu R. J., Johnson L. A., Feinberg A. P. Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat. Genet. 15:1997b;181-185.
26. Leighton P. A., Ingram R. S., Eggenschwiler J., Efstratiadis A., Tilghman S. M. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature. 375:1995a;34-39.
27. Leighton P. A., Saam J. R., Ingram R. S., Stewart C. L., Tilghman S. M. An enhancer deletion affects both H19 and Igf2 expression. Genes Dev. 9:1995b;2079-2089.
28. Li M., Squire J. A., Weksberg R. Molecular genetics of Wiedemann-Beckwith syndrome. Am. J. Med. Genet. 79:1998a;253-259.
29. Li X., Adam G., Cui H., Sandstedt B., Ohlsson R., Ekstrom T. J. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: Uncoupling of IGF2 and H19 imprinting. Oncogene. 11:1995;221-229.
30. Li Y.-M., Franklin G., Cui H.-M., Svensson K., He X.-B., Adam G., Ohlsson R., Pfeifer S. The H19 transcript is associated with polysomes and may regulate IGF2 expression in trans. J. Biol. Chem. 273:1998b;28247-28252.
31. Lichter P., Tang C., Call K., Hermanson G., Evans G., Housman D., Ward D. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science. 247:1990;64-69.
32. Mannens M., Hoovers J. M., Redeker E., Verjaal M., Feinberg A. P., Little P., Boavida M., Coad N., Steenman M., Bliek J. Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann syndrome and various human neoplasia. Eur. J. Hum. Genet. 2:1994;3-23.
33. Milot E., Strouboulis J., Trimborn T., Wijgerde M., de Boer E., Langeveld A., Tan-Un K., Vergeer W., Yannoutsos N., Grosveld F., Fraser P. Heterochromatin effects on the frequency and duration of LCR-mediated gene transcription. Cell. 87:1996;105-114.
34. Morison I. M., Reeve A. E. A catalogue of imprinted genes and parent-of-origin effects in humans and animals. Hum. Mol. Genet. 7:1998;1599-1609.
35. Moulton T., Crenshaw T., Hao Y., Moosikasuwan J., Lin N., Dembitzer F., Hensle T., Weiss L., McMorrow L., Loew T. Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat. Genet. 7:1994;440-447.
36. Neves H., Ramos C., da Silva M. G., Parreira A., Parreira L. The nuclear topography of ABL, BCR, PML, and RARa genes: Evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation. Blood. 93:1999;1197-1207.
37. Nystrom A., Cheetham J. E., Engstrom W., Schofield P. N. Molecular analysis of patients with Wiedemann-Beckwith syndrome. II. Paternally derived disomies of chromosome 11. Eur. J. Pediatr. 151:1992;511-514.
38. KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. Am. J. Hum. Genet. 61:1997;295-303.
39. Pak D. T. S., Pflumm M., Chesnokov I., Huang D. W., Kellum R., Marr J., Romanowski P., Botchan M. R. Association of the origin recognition complex with heterochromatin and HP1 in higher eukaryotes. Cell. 91:1997;311-323.
40. Pettenati M. J., Haines J. L., Higgins R. R., Wappner R. S., Palmer C. G., Weaver D. D. Wiedemann-Beckwith syndrome: Presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Hum. Genet. 74:1986;143-154.
41. Ping A. J., Reeve A. E., Law D. J., Young M. R., Boehnke M., Feinberg A. P. Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am. J. Hum. Genet. 44:1989;720-723.
42. Pueschel S. M., Padre-Mendoza T. Chromosome 11 and Beckwith-Wiedemann syndrome. J. Pediatr. 104:1984;484-485.
43. Qian N., Frank D., O'Keefe D., Dao D., Zhao L., Yuan L., Wang Q., Keating M., Walsh C., Tycko B. The IPL gene on chromosome 11p15.5 is imprinted in humans and mice and is similar to TDAG51, implicated in Fas expression and apoptosis. Hum. Mol. Genet. 6:1997;2021-2029.
44. Reik W., Brown K. W., Schneid H., Le Bouc Y., Bickmore W., Maher E. R. Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by altered imprinting pattern in the IGF2-H19 domain. Hum. Mol. Genet. 4:1995;2379-2385.
45. Reik W., Maher E. R. Imprinting in clusters: Lessons from Beckwith-Wiedemann syndrome. Trends Genet. 13:1997;330-334.
46. Ripoche M.-A., Kress C., Poirier F., Dandolo L. Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element. Genes Dev. 11:1997;1596-1604.
47. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning. A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
48. Schmidt J. V., Levorse J. M., Tilghman S. M. Enhancer competition between H19 and Igf2 does not mediate their imprinting. Proc. Natl. Acad. Sci. USA. 96:1999;9733-9738.
49. Schneid H., Vazquet M. P., Seurin D., le Bouc Y. Loss of heterozygosity in non-tumoral tissue in two children with Beckwith-Wiedemann syndrome. Growth Reg. 1:1991;168-170.
50. Smilinich N. J., Day C. D., Fitzpatrick G. V., Caldwell G. M., Lossie A. C., Cooper P. R., Smallwood A. C., Joyce J. A., Schofield P. N., Reik W., Nicholls R. D., Driscoll D. J., Weksberg R., Maher E. R., Shows T. B., Higgins M. J. A maternally methylated CpG-island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome. Proc. Natl. Acad. Sci. USA. 96:1999;8064-8069.
51. Steenman M. J., Rainier S., Dobry C. J., Grundy P., Horon I. L., Feinberg A. P. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nat. Genet. 7:1994;433-439.
52. Sun F.-L., Dean W. L., Kelsey G., Allen N. D., Reik W. Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature. 389:1997;809-815.
53. Tadokoro K., Fujii H., Inoue T., Yamada M. Polymerase chain reaction (PCR) for detection of Apa1 polymorphism at the insulin like growth factor II gene (IGF2). Nucleic Acids Res. 19:1991.
54. Taniguchi T., Sullivan M. J., Ogawa O., Reeve A. E. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc. Natl. Acad. Sci. USA. 92:1995;2159-2163.
55. Tilghman S. M. The sins of the fathers and mothers: Genomic imprinting in mammalian development. Cell. 96:1999;185-193.
56. van Roozendaal C. E. P., Gillis A. J. M., Klijn J. G. M., van Ooijen B., Claassen C. J. C., Eggermont A. M. M., Henzen-Logmans S. C., Oosterhuis J. W., Foekens J. A., Looijenga L. H. J. Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures. FEBS Letts. 437:1998;107-111.
57. Waziri M., Patil S. R., Hanson J. W., Bartley J. A. Abnormality of chromosome 11 in patients with features of Beckwith-Wiedemann syndrome. J. Paed. 102:1983;873-876.
58. Webber A. L., R. S. I., Levorse J. M., Tilghman S. M. Location of enhancers is essential for the imprinting of H19 and Igf2 genes. Nature. 391:1998;711-715.
59. Weksberg R., Shen D. R., Fei Y. L., Song Q. L., Squire J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat. Genet. 5:1993a;143-150.
60. Weksberg R., Teshima I., Williams B. R., Greenberg C. R., Pueschel S. M., Chernos J. E., Fowlow S. B., Hoyme E., Anderson I. J., Whiteman D. A. Molecular characterization of cytogenetic alterations associated with the Beckwith-Wiedemann syndrome (BWS) phenotype refines the localization and suggests the gene for BWS is imprinted. Hum. Mol. Genet. 2:1993b;549-556.
61. Wiedemann H. R. Tumours and hemihypertrophy associated with the Wiedemann-Beckwith syndrome. Eur. J. Pediatr. 141:1983.
62. Windham C. Q., Jones P. A. Expression of H19 does not influence the timing of replication of the Igf2/H19 imprinted region. Dev. Gen. 20:1997;29-35.
63. Yan Y., Frisen J., Lee M. H., Massague J., Barbacid M. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11:1997;973-983.
64. Zhang P., Liegeois N. J., Wong C., Finegold M., Hou H., Thompson J. C., Silverman A., Harper J. W., DePinho R. A., Elledge S. J. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature. 387:1997;151-158.
65. Zhang Y., Tycko B. Monoallelic expression of the human H19 gene. Nat. Genet. 1:1992;40-44.
66. Zhang Y., Shields T., Crenshaw T., Hao Y., Moulton T., Tycko B. Imprinting of human H19: Allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. Am. J. Hum. Genet. 53:1993;113-124.